Position in TAK
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$672,570
-$90,694 QoQ
Shares Held
41,957
+1.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#37
of 181 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CHOREO, LLC holds $10,662,030 across 14 Drug Manufacturers - Specialty & Generic names. TAK ranks #7 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
184,502 | $1,721,403 | |
| 2 | ALKS |
Alkermes plc.
|
25,815 | $1,352,576 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
35,789 | $1,212,531 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
47,850 | $1,177,588 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
|
17,744 | $838,758 | |
| 6 | ZTS |
Zoetis Inc.
|
11,360 | $816,329 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
41,957 | $672,570 | |
| 8 | AKBA |
Akebia Therapeutics, Inc.
|
562,423 | $641,162 |
All Filings in TAK
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $672,570 | 41,957 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $763,264 | 41,213 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $539,569 | 34,610 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $445,260 | 30,414 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $383,423 | 24,801 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $316,165 | 21,262 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $265,236 | 20,033 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $326,846 | 22,985 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $290,399 | 22,442 | Shares | Sole | 2024-08-07 | |
| No filing history on record for this holder in this stock. | ||||||